Drugs / VM202RY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03404024 | Jan 2018 → Aug 2019 | acute myocardial infarction, myocardial ischemia | Helixmith Co., Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VM202RY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03404024 ↗ |
| Route | Other | “Injected Via Percutaneous Transendocardial Route” NCT03404024 ↗ |